You are on Vetia’s International website.

The packaging image may vary depending on the country in which it is marketed.

Manufacturer

CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription

For futher information, please see the Summary of Product Characteristics (SPC)

BLUEVAC-3

Injectable suspension against Bluetongue virus (BTV), serotype 3.
Target species
Cattle icon
Cattle
Sheep icon
Sheep
Composition
Active substance:

Bluetongue virus (BTV), serotype 3,

strain BTV-3/NET2023, inactivated 106.5 CCID50 *

* CCID50: 50% cell culture infective dose equivalent to titre prior inactivation.


Adjuvant:
Aluminium hydroxide 6 mg
Purified saponin (Quil A) 0,05 mg
Indications
For active immunisation of sheep and cattle to reduce the viraemia, mortality and clinical signs caused by the serotype 3 of the bluetongue virus.
Route of administration
Subcutaneous use.
Dosage
2 ml and 4 ml
Vaccination schedule:
  • Primary vaccination
    • Sheep from 2 months of age:
      Administer two doses of 2 mL subcutaneously 3 weeks apart.
    • Cattle from 2 months of age:
      Administer two doses of 4 mL subcutaneously 3 weeks apart.

  • Revaccination:
    • Not established
Withdrawal period
Zero days
Scroll to Top